Jun 22


Reversing Cognitive Decline with Dr. Dale Bredesen

Thu 23rd June 2022, 06:00pm
Online event

Buy Ticket

Reversing Cognitive Decline

Thursday 23rd June 6pm BST

The Bredesen Protocol is a multi-faceted, holistic, and functional approach used to enhance cognition and reverse cognitive decline. World renowned functional medic Dr. Dale Bredesen, the revolutionary creator of this protocols follows a 4 step process that involves removing exposure triggers that lead to cognitive decline, optimize health support, and rebuild the neural network.

Dementogens or chemicals that contribute to cognitive decline, can be identified by lab tests. If present, it’s vital to detoxify these dementogens. Making yourself aware of your exposure to toxins and finding ways to minimize it is crucial for cognitive success.

Dr. Bredesen also covers specific dietary changes and supplement protocols to further support mental performance.

Join our webinar on Reversing Cognitive Decline using Dr. Dale Bredesen’s  clinically backed protocol.


This webinar will be awarded 1.5 CPD points by the Naturopathic Nutrition Association and the NTOI in according with its guidelines.

Once registered, you will receive three reminder emails – one a week before the webinar, one a day before and one on the day of the webinar. All our webinars are recorded – you will be sent a link to the recording along with all the educational material, presentations, handouts and CPD approximately 24 to 48 hours after the event



Dr. Dale Bredesen

Renowned Alzheimer Expert, Functional Medic and Author

Dr. Bredesen graduated from Caltech and received his MD from Duke.  He served as Resident and Chief Resident in Neurology at UCSF, then postdoctoral fellow with Nobel laureate Prof. Stanley Prusiner.  He was the Founding President of the Buck Institute for Research on Aging.   The Bredesen Laboratory studied basic mechanisms underlying the neurodegenerative process, and the translation into effective therapeutics for Alzheimer’s disease, leading to the publication of over 220 research papers. He established the Alzheimer’s Drug Development Network with Dr. Varghese John, leading to the identification of new classes of therapeutics for Alzheimer’s disease.  His work led to the discovery of subtypes of Alzheimer’s disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer’s disease, with a precision medicine protocol, and a recent successful proof-of-concept trial. Dr. Bredesen is the author of two New York Times best sellers. He is currently a professor at UCLA.